Degradation of methicillin-resistant Staphylococcus aureus biofilms using a chimeric lysin

Biofouling

Volumn 30, Issue 6, 2014, Pages 667-674

  Yang, Hang ^a   Zhang, Yun ^a   Huang, Yanling ^a   Yu, Junping ^a   Wei, Hongping ^a  

^a WUHAN INSTITUTE OF VIROLOGY   (China)

Author keywords

anti biofilm; biofilm; chimeric lysin; methicillin resistant Staphylococcus aureus (MRSA); Staphylococcus aureus; susceptibility

Indexed keywords

ANTIBIOTICS; BACTERIUM; BIOFILM; DEGRADATION; ENZYME ACTIVITY; SCANNING ELECTRON MICROSCOPY;

METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS;

CRYSTAL VIOLET; HYBRID PROTEIN; LYSIN; MUCOPROTEIN;

ANALYSIS OF VARIANCE; BIOFILM; DOSE RESPONSE; DRUG EFFECTS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; SCANNING ELECTRON MICROSCOPY; ULTRASTRUCTURE;

ANALYSIS OF VARIANCE; BIOFILMS; DOSE-RESPONSE RELATIONSHIP, DRUG; GENTIAN VIOLET; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROSCOPY, ELECTRON, SCANNING; MUCOPROTEINS; RECOMBINANT FUSION PROTEINS;

EID: 84902537077     PISSN: 08927014     EISSN: 10292454     Source Type: Journal    
DOI: 10.1080/08927014.2014.905927     Document Type: Article

References (32)

1. Absalon C, Van Dellen K, Watnick PI. 2011. A communal bacterial adhesin anchors biofilm and bystander cells to surfaces. PLoS Pathog. 7:e1002210.10.1371/journal.ppat.1002210
2. Arias CA, Murray BE. 2009. Antibiotic-resistant bugs in the 21st century - a clinical super-challenge. N Engl J Med. 29;360:439-443.10.1056/NEJMp0804651
3. Ceri H, Olson ME, Stremick C, Read RR, Morck D, Buret A. 1999. The Calgary Biofilm Device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J Clin Microbiol. 37:1771-1776.
4. Ceri H, Olson M, Morck D, Storey D, Read R, Buret A, Olson B. 2001. The MBEC assay system: multiple equivalent biofilms for antibiotic and biocide susceptibility testing. Methods Enzymol. 337:377-385.10.1016/S0076-6879(01)37026-X
5. Croes S, Deurenberg RH, Boumans ML, Beisser PS, Neef C, Stobberingh EE. 2009. Staphylococcus aureus biofilm formation at the physiologic glucose concentration depends on the S. aureus lineage. BMC Microbiol. 9:229.10.1186/1471-2180-9-229
6. Daniel A, Euler C, Collin M, Chahales P, Gorelick KJ, Fischetti VA. 2010. Synergism between a novel chimeric lysin and oxacillin protects against infection by methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 54:1603-1612.10.1128/AAC.01625-09
7. Davies D. 2003. Understanding biofilm resistance to antibacterial agents. Nat Rev Drug Discov. 2:114-122.10.1038/nrd1008
8. Domenech M, Garcia E, Moscoso M. 2011. In vitro destruction of Streptococcus pneumoniae biofilms with bacterial and phage peptidoglycan hydrolases. Antimicrob Agents Chemother. 55:4144-4148. 10.1128/AAC.00492-11
9. Donlan RM. 2009. Preventing biofilms of clinically relevant organisms using bacteriophage. Trends Microbiol. 17:66-72.10.1016/j.tim.2008.11.002
10. Estes R, Theusch J, Beck A, Pitrak D, Mullane KM. 2013. Activity of Daptomycin with or without 25 percent ethanol compared to combinations of minocycline, EDTA, and 25 percent ethanol against methicillin-resistant Staphylococcus aureus isolates embedded in biofilm. Antimicrob Agents Chemother. 57:1998-2000.10.1128/AAC.01129-12
11. Fenton M, Keary R, McAuliffe O, Ross RP, O'Mahony J, Coffey A. 2013. Bacteriophage-derived peptidase CHAP(K) eliminates and prevents staphylococcal biofilms. Int J Microbiol. 2013:1-8.10.1155/2013/625341
12. Gould IM, David MZ, Esposito S, Garau J, Lina G, Mazzei T, Peters G. 2012. New insights into meticillin-resistant Staphylococcus aureus (MRSA) pathogenesis, treatment and resistance. Int J Antimicrob Agents. 39:96-104.10.1016/j.ijantimicag.2011.09.028
13. Hall-Stoodley L, Costerton JW, Stoodley P. 2004. Bacterial biofilms: from the natural environment to infectious diseases. Nat Rev Microbiol. 2:95-108. 10.1038/nrmicro821
14. Kallen AJ, Patel PR, O'Grady NP. 2010. Preventing catheter-related bloodstream infections outside the intensive care unit: expanding prevention to new settings. Clin Infect Dis. 51:335-341.10.1086/652977
15. Kelly D, McAuliffe O, Ross RP, Coffey A. 2012. Prevention of Staphylococcus aureus biofilm formation and reduction in established biofilm density using a combination of phage K and modified derivatives. Lett Appl Microbiol. 54:286-291.10.1111/lam.2012.54.issue-4
16. Klevens RM, Morrison MA, Nadle J, Petit S, Gershman K, Ray S, Harrison LH, Lynfield R, Dumyati G, Townes JM, et al. 2007. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA. 298:1763-1771. 10.1001/jama.298.15.1763
17. de Lencastre H, Oliveira D, Tomasz A. 2007. Antibiotic resistant Staphylococcus aureus: a paradigm of adaptive power. Curr Opin Microbiol. 10:428-435. 10.1016/j.mib.2007.08.003
18. Lowy FD. 2003. Antimicrobial resistance: the example of Staphylococcus aureus. J Clin Invest. 111:1265-1273.10.1172/JCI200318535
19. Mataraci E, Dosler S. 2012. In vitro activities of antibiotics and antimicrobial cationic peptides alone and in combination against methicillin-resistant Staphylococcus aureus biofilms. Antimicrobial Agents Chemother. 56:6366-6371.10.1128/AAC.01180-12
20. Meng X, Shi Y, Ji W, Zhang J, Wang H, Lu C, Sun J. 2011. Application of a bacteriophage lysin to disrupt biofilms formed by the animal pathogen Streptococcus suis. App Environ Microbiol. 77:8272-8279.10.1128/AEM.05151-11
21. O'Flaherty S, Ross RP, Coffey A. 2009. Bacteriophage and their lysins for elimination of infectious bacteria. FEMS Microbiol Rev. 33:801-819.10.1111/fmr.2009.33.issue-4
22. Okuda KI, Zendo T, Sugimoto S, Iwase T, Tajima A, Yamada S, Sonomoto K, Mizunoe Y. 2013. Effects of bacteriocins on methicillin-resistant Staphylococcus aureus biofilm. Antimicrob Agents Chemother. 57:5572-5579.
23. Parra-Ruiz J, Bravo-Molina A, Pena-Monje A, Hernandez-Quero J. 2012. Activity of linezolid and high-dose daptomycin, alone or in combination, in an in vitro model of Staphylococcus aureus biofilm. J Antimicrob Chemother. 67:2682-2685.10.1093/jac/dks272
24. Peters BM, Jabra-Rizk MA, O'May GA, Costerton JW, Shirtliff ME. 2012. Polymicrobial interactions: impact on pathogenesis and human disease. Clin Microbiol Rev. 25:193-213.10.1128/CMR.00013-11
25. Peters BM, Ward RM, Rane HS, Lee SA, Noverr MC. 2013. Efficacy of ethanol against Candida albicans and Staphylococcus aureus polymicrobial biofilms. Antimicrob Agents Chemother. 57:74-82. 10.1128/AAC.01599-12
26. Rahman M, Kim S, Kim SM, Seol SY, Kim J. 2011. Characterization of induced Staphylococcus aureus bacteriophage SAP-26 and its anti-biofilm activity with rifampicin. Biofouling. 27:1087-1093.10.1080/08927014.2011.631169
27. Sass P, Bierbaum G. 2006. Lytic activity of recombinant bacteriophage 11 and 12 endolysins on whole cells and biofilms of Staphylococcus aureus. App Environ Microbiol. 73:347-352.
28. Shen Y, Koller T, Kreikemeyer B, Nelson DC. 2013. Rapid degradation of Streptococcus pyogenes biofilms by PlyC, a bacteriophage-encoded endolysin. J Antimicrob Chemother. 68:1818-1824.10.1093/jac/dkt104
29. Singh V, Arora V, Alam MJ, Garey KW. 2012. Inhibition of biofilm formation by esomeprazole in Pseudomonas aeruginosa and Staphylococcus aureus. Antimicrobial Agents Chemother. 56:4360-4364.10.1128/AAC.00544-12
30. Son JS, Lee SJ, Jun SY, Yoon SJ, Kang SH, Paik HR, Kang JO, Choi YJ. 2010. Antibacterial and biofilm removal activity of a podoviridae Staphylococcus aureus bacteriophage SAP-2 and a derived recombinant cell-wall-degrading enzyme. App Microbiol Biotechnol. 86:1439-1449.10.1007/s00253-009-2386-9
31. Wu JA, Kusuma C, Mond JJ, Kokai-Kun JF. 2003. Lysostaphin disrupts Staphylococcus aureus and Staphylococcus epidermidis biofilms on artificial surfaces. Antimicrob Agents Chemother. 47:3407-3414.10.1128/AAC.47.11.3407-3414.2003
32. Yang H, Zhang Y, Yu J, Huang Y, Zhang XE, Wei H. 2014. Novel chimeric lysin with high-level antimicrobial activity against methicillin-resistant Staphylococcus aureus in vitro and in vivo. Antimicrob Agents Chemother. 58:536-542. 10.1128/AAC.01793-13